Pravastatin-Aspirin Combination The Medical Need

1/29/02


Click here to start


Table of Contents

Pravastatin-Aspirin Combination The Medical Need

Consistency of the Efficacy Findings

Pravastatin-Aspirin Patient Population

U.S. Heart Disease Prevalence Is Projected to Double in the Next Half Century

AHA/ACC Guidelines Update in Patients with Atherosclerotic CV Disease

Components of the Treatment Gap in the Secondary Prevention of Coronary Disease

Following New AHA/ACC Guidelines Necessitates High Pill Burden

Improved Compliance with Combination Tablet vs. Dual Therapy

Components of the Treatment Gap in the Secondary Prevention of Coronary Disease

Sub-Optimal Usage at Discharge of CV Therapies with Proven Value

Components of the Treatment Gap in the Secondary Prevention of Coronary Disease

Sub-Optimal Use of Efficacious Statin Doses: The LTAP Study

Sub-Optimal Use of Aspirin in Secondary Prevention

Conclusions

PPT Slide

Author: mmedia3